LMP-1 ve Nazofaringial Karsinoma

LMP-1 ve Nazofaringial Karsinoma

Amaç: Bu çalışmanın amacı nazofaringial karsinomun litik fazı üzerine etkili olduğu düşünülen LMP-1, ile H2O2 , nitrozamin ve nikotinin gibi dış faktörler arasındaki etkileşimi belirlemektir. Materyal ve Metod: insan LMP-1 (GI: 343177335) aminoasid sekansı ile nikotin (ID: 89594), nitrozamin (ID:...

Full description

Bibliographic Details
Main Authors:	Anggun İndah BUDİNİNGRUM, Achmad ROFİ'İ, Suharjono SUHARJONO, Fatchiyah FATCHİYAH
Format:	Article
Language:	English
Published:	Cukurova University 2014-07-01
Series:	Cukurova Medical Journal
Subjects:	h2o2 lmp-1; nasopharyngeal carcinoma nicotine nitrosamine lmp-1 nazofaringial karsinom nikotin nitrozamin. -
Online Access:	https://dergipark.org.tr/tr/pub/cumj/issue/4190/55123?publisher=cu

Similar Items

LMP-1 and Nasopharyngeal Carcinoma (NPC)
by: Anggun Indah Budiningrum, et al.
Published: (2014-06-01)

Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma
by: Saidu Kamara, et al.
Published: (2023-06-01)

Immunohistochemical Identification and Assessment of the Location of Immunoproteasome Subunits LMP2 and LMP7 in Acquired Cholesteatoma
by: Justyna Rutkowska, et al.
Published: (2023-09-01)

Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia
by: Sheng-hong Du, et al.
Published: (2021-01-01)

Subversion of immunoproteasome subunit expression in dengue virus serotype 2-infected HepG2 cells
by: Chye Sheng Gan, et al.

Association Between LMP-1 and p16 Expression with Prognostic Factor of Nasopharyngeal Carcinoma
by: Rizki Widya Nur, et al.
Published: (2023-02-01)

Effect of LMP-1 and mutant p53 on the Prognosis of Undifferentiated Type of Nasopharyngeal Carcinoma
by: Atikah Atikah, et al.
Published: (2022-01-01)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
by: Kousho Wakae, et al.
Published: (2020-10-01)

LMP1-EBV Gene Deletion Mutations and HLA Genotypes of Nasopharyngeal Cancer Patients in Vietnam
by: Cua Thi Hong Trinh, et al.
Published: (2023-01-01)

Contribution of Antigen-Processing Machinery Genetic Polymorphisms to Atopic Dermatitis
by: Wanda Niepiekło-Miniewska, et al.
Published: (2021-04-01)

New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma
by: Kathy H. Y. Shair, et al.
Published: (2018-03-01)

LMP1‐positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling
by: Zhibao Zhang, et al.
Published: (2019-10-01)

LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/β-catenin signaling pathway and EMT in cervical cancer
by: Zhengyan Cheng, et al.
Published: (2023-11-01)

Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
by: Katerina Vrzalikova, et al.
Published: (2018-08-01)

EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models
by: Yanru Guo, et al.
Published: (2023-01-01)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
by: Kina Kase, et al.
Published: (2021-03-01)

Efficient Epstein-Barr Virus Progeny Production Mediated by Cancer-Derived LMP1 and Virally-Encoded microRNAs
by: Misako Yajima, et al.
Published: (2019-04-01)

The Anti-Apoptotic Role of EBV-LMP1 in Lymphoma Cells
by: Zeng M, et al.
Published: (2020-09-01)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
by: Ana Banko, et al.
Published: (2021-08-01)

Latent Membrane Protein 1 (LMP1) from Epstein–Barr Virus (EBV) Strains M81 and B95.8 Modulate miRNA Expression When Expressed in Immortalized Human Nasopharyngeal Cells
by: Barbara G. Müller Coan, et al.
Published: (2022-02-01)

A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
by: Lun-Quan Sun, et al.
Published: (2010-09-01)

Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display
by: Jin Zhu, et al.
Published: (2013-04-01)

Novel Synthetic DNA Immunogens Targeting Latent Expressed Antigens of Epstein–Barr Virus Elicit Potent Cellular Responses and Inhibit Tumor Growth
by: Krzysztof Wojtak, et al.
Published: (2019-05-01)

In vivo and in vitro study of co-expression of LMP1 and Cripto-1 in nasopharyngeal carcinoma
by: Qing Ye, et al.
Published: (2020-09-01)

Cholesterol-dependent molecular mechanisms contribute to cationic amphiphilic drugs’ prevention of silica-induced inflammation
by: Rebekah L. Kendall, et al.
Published: (2023-06-01)

New Look of EBV LMP1 Signaling Landscape
by: Ling Wang, et al.
Published: (2021-10-01)

Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children
by: Ai Junhong, et al.
Published: (2012-01-01)

Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma
by: Qi Yuan, et al.
Published: (2023-07-01)

The Immunoproteasome Subunits LMP2, LMP7 and MECL-1 Are Crucial Along the Induction of Cerebral Toxoplasmosis
by: Timothy French, et al.
Published: (2021-04-01)

A 3-gene signature comprising CDH4, STAT4 and EBV-encoded LMP1 for early diagnosis and predicting disease progression of nasopharyngeal carcinoma
by: Shu-Chen Liu, et al.
Published: (2023-07-01)

Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein–Barr Virus LMP1 Protein
by: Abdelhalim Khenchouche, et al.
Published: (2023-06-01)

Investigação da LMP1 do EBV e a coinfeçcão do HPV em lesões genitais de pacientes infectados ou não pelo HIV Investigation of the LMP1 EBV and co-infection by HPV in genital lesions of patients infected or not by HIV
by: Fabiana Resende Rodrigues, et al.
Published: (2010-10-01)

CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
by: Haifeng Huo, et al.
Published: (2019-10-01)

Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer
by: Sylwia Fołtyn, et al.
Published: (2017-05-01)

Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
by: Zhang Hui, et al.
Published: (2017-06-01)

Real-time detection of LMP1/LMP1 interaction in MβCD-induced apoptosis of nasopharyngeal carcinoma cells using FRET method
by: Zhiwei Wu, et al.
Published: (2019-11-01)

Development of a miniaturised potentiostat for urea detection using the LMP91000
by: Chi Tran Nhu, et al.
Published: (2023-03-01)

Epstein–Barr Virus B Cell Growth Transformation: The Nuclear Events
by: Bo Zhao
Published: (2023-03-01)

Deteksi Gen Laten Membrane Protein-1 Epstein-Barr Virus Pada Karsinoma Nasofaring
by: Uli Nurjanah, et al.
Published: (2017-08-01)

CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
by: Hongwen Li, et al.
Published: (2023-08-01)